Bridgewater Advisors Inc. Abb Vie Inc. Transaction History

Bridgewater Advisors Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$137.62 - $174.96 $28,074 - $35,691	-204 Reduced 6.35%	3,011 $461,000
Q1 2022 May 05, 2022	BUY	$131.98 - $163.75 $89,086 - $110,531	675 Added 26.57%	3,215 $521,000
Q4 2021 Feb 07, 2022	BUY	$107.43 - $135.93 $5,049 - $6,388	47 Added 1.89%	2,540 $344,000
Q3 2021 Nov 02, 2021	BUY	$106.4 - $120.78 $10,852 - $12,319	102 Added 4.27%	2,493 $269,000
Q2 2021 Aug 06, 2021	BUY	$105.21 - $117.21 $251,557 - $280,249	2,391 New	2,391 $269,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Bridgewater Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Bridgewater Advisors Inc. with notifications on news.